People who smoke made their choice and must accept the consequences

The claim

The individual-choice framing holds that smoking is a fully informed, repeatedly ratified adult decision. Cigarette packages carry health warnings; the harms of smoking have been public knowledge since the 1964 Surgeon General’s report. Adults who smoke do so voluntarily and continue to do so each time they purchase a pack. Under this view, asking non-smoking taxpayers to fund the downstream healthcare costs — through Medicaid, Medicare, and VA programs — is a subsidy of freely chosen self-harm, no different from subsidizing any other lifestyle preference. The claim has intuitive appeal as a matter of personal responsibility and has been used to argue against public cessation programs, Medicaid coverage of tobacco-related illness, and graphic warning label mandates.

The evidence supports the claim partially. Adult smokers do continue to purchase cigarettes, and some fraction do successfully quit when motivated. But the claim rests on a model of initial choice that is systematically undermined by the age at which most smokers begin, the industry’s documented history of targeting children and deceiving the public about addiction, and the neurological reality of nicotine dependence. The claim is not wholly false — individual agency is real — but it is deployed at a level of simplification that obscures the structural conditions that produce smoking populations.

The mechanism

The choice frame assumes an informed adult decision. For the claim to hold, smoking initiation should occur among adults who have evaluated the risks and decided the benefits outweigh them. That is the decision model embedded in the argument. Under this model, public funds should not compensate people for accepting known risks — to do so would generate moral hazard, encouraging other risky behaviors in the expectation of public subsidy.

Where the mechanism fails: initiation age. The most direct empirical challenge is that smoking rarely begins in informed adulthood. The 2012 Surgeon General’s report found that 87 percent of adult daily smokers began before age 18. The median age of initiation in the United States is approximately 15. Adolescent brains are neurologically distinct from adult brains — the prefrontal cortex, which governs long-term risk assessment and impulse control, is not fully developed until the mid-twenties. Decisions made at 15 under conditions of social pressure, aggressive marketing, and incomplete risk perception do not map cleanly onto the liberal model of autonomous adult choice that the claim requires.

Where the mechanism fails: addiction. Nicotine is a potent addictive substance with a well-characterized mechanism. It acts on nicotinic acetylcholine receptors, producing dopamine release in the mesolimbic pathway — the same reward circuit central to other addictive substances. Chronic nicotine exposure produces neuroadaptation: receptors upregulate, baseline dopamine falls, and cessation produces a genuine withdrawal syndrome including dysphoria, anxiety, and impaired concentration. Unaided quit attempts succeed in sustained abstinence approximately 3-5 percent of the time at one year. This is not consistent with a simple preference that can be reversed by decision. Continued smoking is substantially driven by dependence, not renewed choice.

Where the mechanism has partial force: adult continuation. The choice frame is weakest on initiation and strongest on continuation among adults who have been fully informed, have access to cessation programs, and are not facing acute poverty-related stress. Some share of adult smokers do quit — quit rates rose substantially in the United States after price increases, smoke-free air legislation, and cessation program expansion. Individual variation in quit success is real. The claim is not entirely without empirical basis; it is overstated, not entirely fabricated.

The evidence

Industry deception and the Tobacco Master Settlement Agreement. The most damaging evidence against the pure-choice frame comes from the tobacco industry’s own internal documents, disclosed through litigation culminating in the 1998 Tobacco Master Settlement Agreement and the 2006 federal RICO judgment in United States v. Philip Morris USA. Judge Gladys Kessler’s 1,683-page ruling found that the major tobacco companies had for decades: knowingly deceived the public about the health effects of smoking, suppressed research on addiction, manipulated nicotine levels to sustain addiction, and specifically targeted youth as replacement smokers for adults who died or quit. The phrase “replacement smokers” appears in internal RJ Reynolds documents; Project SCUM (Subculture Urban Marketing), a 1995 RJ Reynolds project, explicitly targeted homeless youth and gay men in San Francisco. These are not allegations — they are findings of a federal court after full trial.

Naomi Oreskes and Erik Conway’s Merchants of Doubt documents the tobacco industry’s systematic campaign to manufacture scientific uncertainty about smoking harms, a playbook subsequently adopted by the fossil fuel industry. For decades after the internal science was clear, the public was presented with manufactured controversy. The claim that smokers made an informed choice during those decades is directly contradicted by evidence that information was deliberately suppressed.

Youth targeting and the initiation age. The tobacco industry consistently denied targeting youth while simultaneously conducting research on youth brand preferences, placing advertising near schools and in youth-oriented magazines, and using cartoon characters (Joe Camel, Marlboro Man) with documented appeal to teenagers. Joe Camel — introduced in 1988, removed after legal pressure in 1997 — was shown in studies to be as recognizable to six-year-olds as Mickey Mouse. The Federal Trade Commission found in 1997 that Camel advertising had successfully shifted market share toward underage smokers. A choice framework that ignores deliberate pediatric marketing of an addictive product operates on a fiction.

Socioeconomic gradient of smoking. Smoking is not randomly distributed across the population. US adults below the poverty line smoke at roughly 21 percent, compared to 13 percent above it. This gradient is not primarily explained by preference differences: low-income communities face higher stress loads (a documented trigger for nicotine craving), have been more intensively targeted by tobacco company marketing (menthol cigarettes and high-density advertising in Black and low-income neighborhoods are extensively documented), and have lower access to evidence-based cessation programs, nicotine replacement therapies, and the healthcare providers who recommend them. If smoking were purely a choice uniformly available to all, we would not expect this systematic concentration in precisely the populations with the least structural power.

Natural experiments: Australia, UK, and Canada. The strongest evidence that the choice frame understates structural determinism comes from comparative policy experiments. Australia implemented standardized plain packaging in 2012 — cigarettes sold in drab olive packaging without brand imagery, with graphic health warnings covering 75 percent of the front and 90 percent of the back. Daily smoking prevalence fell from 15.1 percent in 2013 to 11.0 percent in 2019. The UK, Canada, and France subsequently adopted similar measures. If smoking were purely a stable individual preference unaffected by marketing and packaging design, these interventions would have no effect. They have consistent, documented effects. The responsiveness of smoking rates to branding restrictions is itself evidence that tobacco companies created demand conditions that exceeded individual autonomy.

Price elasticity studies consistently find that a 10 percent price increase reduces cigarette consumption by approximately 4 percent among adults and 7 percent among youth — with youth roughly twice as price-sensitive. Taxation works as a cessation tool, particularly for initiation prevention. This means that public policy — not just individual willpower — is a primary driver of whether people smoke.

The taxpayer subsidy question: a more complex accounting. Even accepting the choice frame in part, the taxpayer subsidy argument contains an internal contradiction. Economists including Kip Viscusi have argued that when accounting for early mortality, smokers collect less in Social Security, Medicare, and pension benefits than non-smokers — meaning that on a lifetime net basis, smokers may impose zero net fiscal burden and in some accounting frameworks a net fiscal benefit. This analysis is contested (it omits secondhand smoke costs, fire costs, lost productivity), but it substantially complicates the claim that smokers are net subsidized. The argument is more morally intuitive than empirically robust.

Who benefits

The individual-choice frame benefits the tobacco industry directly by displacing responsibility for addiction and disease onto consumers. Altria (Philip Morris USA), Philip Morris International, Reynolds American (now part of British American Tobacco), and Lorillard have historically funded advocacy organizations and think tanks — including the Cato Institute, Heartland Institute, and Pacific Research Institute — that amplify personal-responsibility arguments about smoking. These organizations opposed graphic warning label mandates, plain packaging, menthol cigarette restrictions, and Medicaid coverage of cessation programs using choice-based arguments.

The frame also benefits politicians opposing Medicaid expansion, who use it to argue that public health spending rewards irresponsibility. Insurance industry actors who prefer actuarial rating (charging smokers higher premiums) over risk pooling also benefit from a framework that establishes smoking as a choice rather than an addiction.

The counter

The individual-choice position is not entirely without force, and it is worth stating its strongest version. First, in 2025, no adult in the United States can plausibly claim ignorance of smoking’s health consequences — graphic warnings, anti-smoking campaigns, and decades of public health messaging have saturated the information environment. Second, meaningful numbers of smokers do successfully quit: quit rates increased substantially in the US between 1965 and the present, driven partly by motivation and individual effort as well as policy. Third, treating all smoking as addiction-driven and none as adult preference risks paternalism — some people knowingly choose to continue smoking, valuing the pleasure and accepting the risk, and there is a legitimate debate about how far public health policy should override autonomous adult preferences.

On the fiscal subsidy question specifically: cessation programs are highly cost-effective (the cost-per-quality-adjusted-life-year of smoking cessation interventions is well below standard willingness-to-pay thresholds), meaning that funding them is not a question of rewarding bad choices but of efficient healthcare spending. But if one accepts the premise that public programs should be allocated on cost-effectiveness grounds, the choice frame is not doing meaningful work in the argument anyway.

The most defensible version of the claim is: adult smokers who have full information, access to cessation programs, and are not in acute addiction distress bear genuine moral responsibility for their continuation of smoking, and this responsibility is relevant to how we think about public subsidy. This is meaningfully different from the strong version of the claim that smokers simply chose their fate and should bear all consequences alone.

References

Surgeon General of the United States. (2012). Preventing tobacco use among youth and young adults: A report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention. https://www.cdc.gov/tobacco/data_statistics/sgr/2012/index.htm

Kessler, G. (2006). United States v. Philip Morris USA Inc., 449 F. Supp. 2d 1 (D.D.C. 2006).

Australian Institute of Health and Welfare. (2020). National Drug Strategy Household Survey 2019. Drug Statistics Series No. 32. Cat. no. PHE 270. AIHW. https://www.aihw.gov.au/reports/illicit-use-of-drugs/national-drug-strategy-household-survey-2019

Oreskes, N., & Conway, E. M. (2010). Merchants of doubt: How a handful of scientists obscured the truth on issues from tobacco smoke to global warming. Bloomsbury Press.

Hughes, J. R., Keely, J., & Naud, S. (2004). Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction, 99(1), 29–38. https://doi.org/10.1111/j.1360-0443.2004.00540.x

West, R. (2017). Tobacco smoking: Health impact, prevalence, correlates and interventions. Psychology & Health, 32(8), 1018–1036. https://doi.org/10.1080/08870446.2017.1325890

Chaloupka, F. J., & Warner, K. E. (2000). The economics of smoking. In A. J. Culyer & J. P. Newhouse (Eds.), Handbook of health economics (Vol. 1B, pp. 1539–1627). Elsevier. https://doi.org/10.1016/S1574-0064(00)80042-6

Viscusi, W. K. (1995). Cigarette taxation and the social consequences of smoking. Tax Policy and the Economy, 9, 51–101. https://doi.org/10.1086/tpe.9.20061807

Centers for Disease Control and Prevention. (2020). Smoking and tobacco use: Adult data. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm

Babb, S., Malarcher, A., Schauer, G., Asman, K., & Jamal, A. (2017). Quitting smoking among adults — United States, 2000–2015. Morbidity and Mortality Weekly Report, 65(52), 1457–1464. https://doi.org/10.15585/mmwr.mm6552a1